Forza X1, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000173112224001809 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$12.80M
YoY Change		0.28%
Cash & Equivalents	$7.200M	$9.822M
Short-Term Investments		$2.982M
Other Short-Term Assets		$73.51K
YoY Change		-85.86%
Inventory	$60.65K	$493.5K
Prepaid Expenses
Receivables	$125.0K	$0.00
Other Receivables
Total Short-Term Assets	$7.554M	$13.37M
YoY Change	-53.49%	0.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.388M	$3.469M
YoY Change	317.16%	353.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$7.520K
YoY Change		0.0%
Other Assets
YoY Change
Total Long-Term Assets	$4.403M	$3.552M
YoY Change	280.7%	279.86%
TOTAL ASSETS
Total Short-Term Assets	$7.554M	$13.37M
Total Long-Term Assets	$4.403M	$3.552M
Total Assets	$11.96M	$16.92M
YoY Change	-31.28%	18.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$73.07K	$86.82K
YoY Change	89.72%	-12.33%
Accrued Expenses	$9.712K	$462.4K
YoY Change	-86.86%	398.43%
Deferred Revenue	$6.175K	$5.700K
YoY Change		7.55%
Short-Term Debt		$201.9K
YoY Change		18.84%
Long-Term Debt Due		$17.31K
YoY Change
Total Short-Term Liabilities	$113.8K	$842.6K
YoY Change	-49.73%	85.92%
LONG-TERM LIABILITIES
Long-Term Debt		$58.72K
YoY Change
Other Long-Term Liabilities		$0.00
YoY Change		-100.0%
Total Long-Term Liabilities		$58.72K
YoY Change		-14.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$113.8K	$842.6K
Total Long-Term Liabilities		$58.72K
Total Liabilities	$180.9K	$901.3K
YoY Change	-37.57%	72.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.92M	-$10.02M
YoY Change	72.98%	145.15%
Common Stock	$15.78K	$15.78K
YoY Change	0.0%	51.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$21.38K	$21.38K
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.78M	$16.02M
YoY Change
Total Liabilities & Shareholders Equity	$11.96M	$16.92M
YoY Change	-31.28%	18.98%

Cashflow Statement

Concept	2024 Q4	2024 Q3	2023 Q4

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	217455	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001901305
	dei	City Area Code CityAreaCode	772
	dei	Local Phone Number LocalPhoneNumber	429-2525
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	FRZA
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15784000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15784000	shares
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	29226	shares
CY2024Q3	us-gaap	Revenues Revenues	0	usd
CY2023Q3	us-gaap	Revenues Revenues	18559	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	11922	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	11621	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	-11922	usd
CY2024Q3	us-gaap	Salaries And Wages SalariesAndWages	356650	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	77494	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	60667	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	140865	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	92505	usd
CY2024Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	64689	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50482	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	852451	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1258966	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-864373	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1252028	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	3424	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41469
	dei	Entity Registrant Name EntityRegistrantName	FORZA X1, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3159685
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15754774	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7200427	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	125000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2024Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2981720	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	60645	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	493460	usd
CY2024Q3	FRZA	Due From Affiliated Companies Net DueFromAffiliatedCompaniesNet	87884	usd
CY2023Q4	FRZA	Due From Affiliated Companies Net DueFromAffiliatedCompaniesNet	0	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	80095	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73508	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	7554051	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	13370219	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7629	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2024Q3	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4388229	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3468961	usd
CY2024Q3	us-gaap	Assets Assets	11957426	usd
CY2023Q4	us-gaap	Assets Assets	16921844	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	73067	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	86820	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9712	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2024Q3	FRZA	Due To Affiliated Companies Net Current DueToAffiliatedCompaniesNetCurrent	0	usd
CY2023Q4	FRZA	Due To Affiliated Companies Net Current DueToAffiliatedCompaniesNetCurrent	201848	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24847	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17313	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6175	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5700	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	113801	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	842594	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	67070	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	58717	usd
CY2024Q3	us-gaap	Liabilities Liabilities	180871	usd
CY2023Q4	us-gaap	Liabilities Liabilities	901311	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15754774	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15754774	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	29226	shares
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	21379	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	21379	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26697988	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26046873	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14915838	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10020745	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	11776555	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11957426	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16921844	usd
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Revenues Revenues	18559	usd
	us-gaap	Cost Of Revenue CostOfRevenue	68335	usd
	us-gaap	Cost Of Revenue CostOfRevenue	102358	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	6938	usd
	us-gaap	Gross Profit GrossProfit	-68335	usd
	us-gaap	Gross Profit GrossProfit	-83799	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	212753	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	737269	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	906432	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	837857	usd
	us-gaap	Salaries And Wages SalariesAndWages	1479501	usd
	us-gaap	Salaries And Wages SalariesAndWages	2565460	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	587599	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1024787	usd
	us-gaap	Professional Fees ProfessionalFees	391971	usd
	us-gaap	Professional Fees ProfessionalFees	286411	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1674000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	184441	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	134408	usd
	us-gaap	Operating Expenses OperatingExpenses	5054781	usd
	us-gaap	Operating Expenses OperatingExpenses	4917498	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5123116	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5001297	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1144	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	7362	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	2928	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	62830	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	1401	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	62830	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	1401	usd
CY2024Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	31852	usd
CY2023Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	150284	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	276862	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	412551	usd
CY2024Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	31426	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-16930	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	31426	usd
CY2024Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2023Q3	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	23747	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	35210	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	23747	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-172684	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-172684	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2024Q3	FRZA	Gain On Sale Of R And D Assets GainOnSaleOfRAndDAssets	50097	usd
CY2023Q3	FRZA	Gain On Sale Of R And D Assets GainOnSaleOfRAndDAssets	0	usd
	FRZA	Gain On Sale Of R And D Assets GainOnSaleOfRAndDAssets	50097	usd
	FRZA	Gain On Sale Of R And D Assets GainOnSaleOfRAndDAssets	0	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31329	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	205714	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	228023	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	466197	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-895702	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-1046314	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-4895093	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-4535100	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-895702	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1046314	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4895093	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4535100	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15754774	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15754774	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15784000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15784000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15754774	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15754774	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12579866	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12579866	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341163	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2005132	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12036234	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6929552	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341817	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1483654	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17823949	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	332107	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1046314	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	17109742	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	293141	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1167837	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	15145837	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	183815	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-2831554	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	12498098	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	174159	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-895702	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	11776555	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4895093	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4535100	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	184441	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	134408	usd
	FRZA	Change In Fair Value Of Marketable Securities Available For Sale ChangeInFairValueOfMarketableSecuritiesAvailableForSale	-16930	usd
	FRZA	Change In Fair Value Of Marketable Securities Available For Sale ChangeInFairValueOfMarketableSecuritiesAvailableForSale	31426	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1674000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	651115	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1015087	usd
	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	67518	usd
	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	64869	usd
	FRZA	Gain On Sale Of R And D Assets GainOnSaleOfRAndDAssets	50097	usd
	FRZA	Gain On Sale Of R And D Assets GainOnSaleOfRAndDAssets	-0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-172684	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-0	usd
	FRZA	Change In Inventory Reserve ChangeInInventoryReserve	293058	usd
	FRZA	Change In Inventory Reserve ChangeInInventoryReserve	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	125000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-139757	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	777831	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6587	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-394739	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-13753	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-60515	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-452669	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-18869	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-68532	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-63853	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	475	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	500	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2411753	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3877991	usd
	FRZA	Net Redemptions Purchase Of Marketable Securities NetRedemptionsPurchaseOfMarketableSecurities	-3000000	usd
	FRZA	Net Redemptions Purchase Of Marketable Securities NetRedemptionsPurchaseOfMarketableSecurities	9841346	usd
	FRZA	Realized Gain On Sale Of Marketable Securities RealizedGainOnSaleOfMarketableSecurities	35210	usd
	FRZA	Realized Gain On Sale Of Marketable Securities RealizedGainOnSaleOfMarketableSecurities	23747	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2874724	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	328534	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	96066	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10193627	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6996015	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	-0	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	66463	usd
	FRZA	Repayments Of Finance Lease RepaymentsOfFinanceLease	15685	usd
	FRZA	Repayments Of Finance Lease RepaymentsOfFinanceLease	11844	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	393969	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	755299	usd
	FRZA	Advances From Affiliates AdvancesFromAffiliates	104237	usd
	FRZA	Advances From Affiliates AdvancesFromAffiliates	580830	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-305417	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6743239	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2621104	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7328379	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9821531	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7200427	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5438820	usd
	us-gaap	Interest Paid Net InterestPaidNet	7362	usd
	us-gaap	Interest Paid Net InterestPaidNet	2928	usd
	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases	31572	usd
	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases	92405	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1674000	usd
CY2024Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	6175	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	5700	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_z0JsUtYN9ROf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"><b><span id="xdx_863_zdiyO6CyjX05">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7200427	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zR9wrUph2zt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"><b><span id="xdx_861_zs1xTmwXuW97">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_907_ecustom--FdicInsuredLimit_iI_c20240930_zPaTUhXJYLaa" title="FDIC insured limit">250,000</span> are at risk. At September 30, 2024 and December 31, 2023, the Company had $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240930_zF7fuhcXzFx9" title="FDIC excess amount">6,920,427</span> and $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zy2t1SUqh5fj" title="FDIC excess amount">9,557,799</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2024Q3	FRZA	Fdic Insured Limit FdicInsuredLimit	250000	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	6920427	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	9557799	usd
CY2024Q3	us-gaap	Other Inventory OtherInventory	58100	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	351158	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7200427	usd
CY2024Q3	FRZA	Working Capital WorkingCapital	7440250	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2023Q4	FRZA	Working Capital WorkingCapital	12527625	usd
CY2023Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	6929552	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4895093	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4535100	usd
CY2023Q4	FRZA	Marketable Securities Amortized Cost MarketableSecuritiesAmortizedCost	2930842	usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Gains MarketableSecuritiesGrossUnrealizedGains	50878	usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Losses MarketableSecuritiesGrossUnrealizedLosses	0	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	2981720	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	2981720	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4760266	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3703373	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	372037	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	234412	usd
CY2024Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	4388229	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3468961	usd
CY2024Q3	us-gaap	Depreciation Depreciation	64689	usd
CY2023Q3	us-gaap	Depreciation Depreciation	50482	usd
	us-gaap	Depreciation Depreciation	184441	usd
	us-gaap	Depreciation Depreciation	134408	usd
CY2022Q4	FRZA	Treasury Stock Acquired Average Cost Precentage TreasuryStockAcquiredAverageCostPrecentage	0.0033	pure
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	7742	usd
CY2024Q3	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7629	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68532	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	68665	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	68665	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	22888	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	22888	usd
CY2023Q1	FRZA	Net Asset Value NetAssetValue	48826	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.030	pure
CY2023Q1	FRZA	Net Asset Value NetAssetValue	43579	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q1	FRZA	Net Asset Value NetAssetValue	33393	usd
CY2024Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24847	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	67070	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	7233	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	28931	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	28931	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	28931	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	6409	usd
CY2024Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	100435	usd
CY2024Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	8518	usd
CY2024Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	91917	usd
CY2024Q3	FRZA	Due From Affiliates Net Current DueFromAffiliatesNetCurrent	87884	usd
CY2023Q4	FRZA	Due To Affiliated Companies Net Current DueToAffiliatedCompaniesNetCurrent	201848	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	393969	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	755299	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	104237	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	580830	usd
CY2022Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments	2500	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	7500	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	12500	usd
CY2024Q3	FRZA	Aggregate Common Stock Share AggregateCommonStockShare	5355000	shares
CY2024Q3	FRZA	Common Stock Share To Be Cancelled CommonStockShareToBeCancelled	7000000	shares
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	9712	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	59177	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	403204	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9712	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	172500	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.25
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	306705	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.88
CY2024Q3	FRZA	Warrant Activity WarrantActivity	0	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	651115	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1015087	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.12	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.15	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0362	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1441500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.41
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y18D
CY2022Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	518000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.70
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P9Y9M3D
CY2023	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	287835	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	69583	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.24
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P9Y7M13D
CY2023	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited	-40248	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1889917	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y4M9D
CY2023Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4257500	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	791843	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.39
	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P8Y10M6D
	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited	-2266938	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1098074	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.75
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y3M10D
CY2024Q3	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	1990562	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	893972	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.38
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y1M9D
CY2023Q4	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30	integer
CY2023Q4	FRZA	Bid Price Per Share BidPricePerShare	1.00
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-001809-index-headers.html	Edgar Link	pending
0001731122-24-001809-index.html	Edgar Link	pending
0001731122-24-001809.txt	Edgar Link	pending
0001731122-24-001809-xbrl.zip	Edgar Link	pending
e6125_10q.htm	Edgar Link	pending
e6125_ex31-1.htm	Edgar Link	pending
e6125_ex31-2.htm	Edgar Link	pending
e6125_ex32-1.htm	Edgar Link	pending
e6125_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frza-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
frza-20240930_cal.xml	Edgar Link	unprocessable
frza-20240930_def.xml	Edgar Link	unprocessable
frza-20240930_lab.xml	Edgar Link	unprocessable
frza-20240930_pre.xml	Edgar Link	unprocessable
e6125_10q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Forza X1, Inc.

2024 Q4 Form 10-Q Financial Statement

#000173112224001809 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission